Search results
Results from the WOW.Com Content Network
Target ClearRx prescription bottles. ClearRx is a trademark for a design for prescription drug packaging, designed by design student Deborah Adler as a thesis project and adopted by Target Corporation (with refinements by industrial designer Klaus Rosburg) for use in their in-store pharmacies in 2005. [1]
Designer drugs are structural or functional analogues of controlled substances that are designed to mimic the pharmacological effects of the parent drug while avoiding detection or classification as illegal.
Deborah Adler (born 1975) is an American designer. A native of Chappaqua, New York, Adler is the daughter of a doctor and a nurse. She attended the University of Vermont, receiving her BFA in 1997. [1] Adler then studied design at the School of Visual Arts under Steven Heller and Lita Talarico. During this time, her grandmother became ill ...
Other designer drugs were prepared for the first time in clandestine laboratories. [4] Because the efficacy and safety of these substances have not been thoroughly evaluated in animal and human trials, the use of some of these drugs may result in unexpected side effects. [5] The development of designer drugs may be considered a subfield of drug ...
Following its sale as a designer drug, U-47700 was made illegal in Sweden on January 26, 2016. [50] U-47700 was emergency scheduled in Ohio on May 3, 2016, by executive order of Governor John Kasich. [51] U-47700 was emergency scheduled in Florida on September 27, 2016, by an emergency rule of Florida Attorney General Pam Bondi. [52]
In Europe about 85% of solid unit doses are packed in blister packs with only about 20% in North America. [5] Blister packs are pre-formed plastic/paper/foil packaging used for formed solid drugs. The primary component of a blister pack is a cavity or pocket made from a thermoformed plastic.
The sensor begins transmitting medical data after it is consumed. The technology that makes up the pill, as well as the data transmitted by the pill's sensor, are considered to be part of digital medicine. The purpose of the sensor is to determine whether the person is taking their medication or not (called "compliance").
The company was founded in 2013 by TJ Parker and Elliot Cohen. [2] By 2014 the IDEO incubated company was licensed in 31 states and shipping medication in dosage packets with robots handling the packaging process. [3]